Skip to contentLirea is launching soon. Join the waitlist to be notified.

Peptide tracker

In clinical trials

Cagrilintide tracker

cagrilintide, tracked privately: the weekly amylin shot.

Cagrilintide is a weekly amylin analog studied for weight management, often paired with a GLP-1 (it's the "Cagri" half of CagriSema). Whether you're in a trial or tracking it yourself, Lirea keeps a private record of your dose and your trend, kept on your phone, with no account.

One email on launch day, and nothing else. The app itself never asks for one.

Today

On your schedule

This week

Cagrilintide

on schedule

Logged

Weight check-in

trend
Log a dose

What you'll track

Made for how you actually take Cagrilintide.

A once-weekly subcutaneous injection.

A weekly shot, reminded

Pick your day; Lirea reminds you before it's due and logs it in one tap.

Track a long, slow climb

Cagrilintide is stepped up gradually over several weeks. Lirea shows which step you're on and lets you hold a level if you need to.

Often paired with a GLP-1

Many people run cagrilintide alongside semaglutide, tirzepatide, or retatrutide. Lirea keeps both on one private schedule.

Weight as the outcome that matters

Follow your weight as a trend over months, not a daily number.

Why Lirea

Your Cagrilintide data is nobody's business but yours.

No employer, insurer, or wellness platform ever sees what you log, and neither do we. It's stored and encrypted on your device, with no account and no server in the middle.

How your data stays yours
  • No account

    Open the app and start. We never ask who you are.

  • On-device

    Your data is stored and encrypted on your phone.

  • No analytics SDKs

    No Firebase, no trackers, no ad networks.

  • Check it yourself

    Turn on airplane mode. Everything but the paywall still works, because there is nothing on the other end.

Questions

Cagrilintide, tracked privately

Is cagrilintide a GLP-1?

No, it's an amylin analog, a different appetite mechanism. It's often combined with a GLP-1 (as in CagriSema) for a complementary effect. Lirea tracks it either on its own or alongside your GLP-1.

Is cagrilintide approved?

Standalone cagrilintide is not FDA-approved (the CagriSema combination is under FDA review). Lirea does not sell or supply it, it's a private tracker.

Can I track cagrilintide and my GLP-1 together?

Yes. Keep both on one private schedule, with the history encrypted on your device.

Related trackers

Lirea is a private tracking tool, not a medical device, a pharmacy, or a source of medical advice. Anything shown here is general reference, not a recommendation. Many peptides are not approved by the FDA and are sold for research use only; Lirea neither sells nor supplies any compound. Always follow the guidance of a qualified healthcare provider.

Launching soon

Keep it, and keep it yours.

Track your weekly dose, your titration, and how you’re feeling, all on your device. No account required. Be first to know when Lirea is live.

One email at launch. No spam, unsubscribe anytime. This list is separate from the app, and we never receive your health data. Privacy.

App Store, soonGoogle Play, soon